ZA201106056B - Protein biomarkers for soft tissue disease diagnosis and as therapeutic targets for oral care intervention - Google Patents

Protein biomarkers for soft tissue disease diagnosis and as therapeutic targets for oral care intervention

Info

Publication number
ZA201106056B
ZA201106056B ZA2011/06056A ZA201106056A ZA201106056B ZA 201106056 B ZA201106056 B ZA 201106056B ZA 2011/06056 A ZA2011/06056 A ZA 2011/06056A ZA 201106056 A ZA201106056 A ZA 201106056A ZA 201106056 B ZA201106056 B ZA 201106056B
Authority
ZA
South Africa
Prior art keywords
soft tissue
oral care
tissue disease
disease diagnosis
therapeutic targets
Prior art date
Application number
ZA2011/06056A
Other languages
English (en)
Inventor
Harsh M Trivedi
Ying Yang
Tao Xu
Original Assignee
Colgate Palmolive Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Colgate Palmolive Co filed Critical Colgate Palmolive Co
Publication of ZA201106056B publication Critical patent/ZA201106056B/en

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56911Bacteria
    • G01N33/56955Bacteria involved in periodontal diseases
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90Enzymes; Proenzymes
    • G01N2333/914Hydrolases (3)
    • G01N2333/948Hydrolases (3) acting on peptide bonds (3.4)
    • G01N2333/95Proteinases, i.e. endopeptidases (3.4.21-3.4.99)
    • G01N2333/964Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue
    • G01N2333/96425Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals
    • G01N2333/96427Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals in general
    • G01N2333/9643Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals in general with EC number
    • G01N2333/96486Metalloendopeptidases (3.4.24)
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/60Complex ways of combining multiple protein biomarkers for diagnosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Biotechnology (AREA)
  • Virology (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
ZA2011/06056A 2009-04-01 2011-08-17 Protein biomarkers for soft tissue disease diagnosis and as therapeutic targets for oral care intervention ZA201106056B (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US16567409P 2009-04-01 2009-04-01
PCT/US2010/029674 WO2010115034A2 (en) 2009-04-01 2010-04-01 Protein biomarkers for soft tissue disease diagnosis and as therapeutic targets for oral care intervention

Publications (1)

Publication Number Publication Date
ZA201106056B true ZA201106056B (en) 2015-05-27

Family

ID=42813186

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA2011/06056A ZA201106056B (en) 2009-04-01 2011-08-17 Protein biomarkers for soft tissue disease diagnosis and as therapeutic targets for oral care intervention

Country Status (15)

Country Link
US (1) US8753820B2 (enExample)
EP (1) EP2414837B1 (enExample)
JP (1) JP5643288B2 (enExample)
CN (1) CN102549432B (enExample)
AR (1) AR076041A1 (enExample)
BR (1) BRPI1013184A2 (enExample)
CA (1) CA2753718C (enExample)
CO (1) CO6430490A2 (enExample)
MX (1) MX2011008439A (enExample)
MY (1) MY179250A (enExample)
RU (1) RU2523383C2 (enExample)
SG (1) SG173461A1 (enExample)
TW (1) TWI481870B (enExample)
WO (1) WO2010115034A2 (enExample)
ZA (1) ZA201106056B (enExample)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR076177A1 (es) * 2009-04-01 2011-05-26 Colgate Palmolive Co MÉTODO PARA IDENTIFICAR UN COMPUESTO uTIL PARA TRATAR UNA ENFERMEDAD O CONDICIoN DE LA CAVIDAD ORAL
US9949671B2 (en) 2013-03-13 2018-04-24 Orthoaccel Technologies, Inc. Diagnostic mouthpieces
WO2018129043A1 (en) * 2017-01-03 2018-07-12 The Trustees Of The University Of Pennsylvania Compositions and methods for predicting risk of preterm birth
EP3631462A1 (en) * 2017-05-24 2020-04-08 Koninklijke Philips N.V. Diagnostics of gingivitis based on salivary il-1beta and hgf
EP3631458A1 (en) * 2017-05-24 2020-04-08 Koninklijke Philips N.V. Diagnostics of periodontitis based on salivary hgf and mmp-8
US12050223B2 (en) 2017-05-24 2024-07-30 Koninklijke Philips N.V. Diagnostics of mild or advanced periodontitis based on salivary IL-1BETA and MMP-9
WO2019084351A1 (en) 2017-10-27 2019-05-02 The Regents Of The University Of California SALIVARY EXTRACELLULAR RNA BIOMARKERS FOR GINGIVITIS
EP3477306A1 (en) * 2017-10-30 2019-05-01 Koninklijke Philips N.V. Classification of periodontitis patients

Family Cites Families (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3538230A (en) 1966-12-05 1970-11-03 Lever Brothers Ltd Oral compositions containing silica xerogels as cleaning and polishing agents
US4358437A (en) 1978-11-29 1982-11-09 Beecham Group Limited Compositions
US5288480A (en) 1987-01-30 1994-02-22 Colgate-Palmolive Co. Antiplaque antibacterial oral composition
GB9117140D0 (en) 1991-08-08 1991-09-25 Unilever Plc Treatment of periodontitis
DE4226043A1 (de) 1992-08-06 1994-02-10 Haarmann & Reimer Gmbh Mittel mit physiologischem Kühleffekt und für diese Mittel geeignete wirksame Verbindungen
EP0728017A1 (en) 1993-11-10 1996-08-28 Bristol-Myers Squibb Company Treatment of bacterially-induced inflammatory diseases
US5578295A (en) 1995-04-28 1996-11-26 The Procter & Gamble Company Oral care compositions comprising certain substituted diphenyl ethers
DE29724204U1 (de) 1996-06-12 2000-09-21 Cognis Deutschland GmbH, 40589 Düsseldorf Kosmetische und/oder pharmazeutische Zubereitungen
FR2794457B1 (fr) 1999-06-01 2001-08-10 Oreal Derives carbonates de retinol, procede de preparation et utilisations
PT2295968E (pt) 1999-12-03 2013-01-09 Baxter Int Teste de pirogenicidade para utilização com sistemas automatizados de imunoensaio
GB0001704D0 (en) 2000-01-25 2000-03-15 Glaxo Group Ltd Protein
JP2003530130A (ja) 2000-04-14 2003-10-14 メタボロン インコーポレイテッド メタボロミクスを使用した薬物発見、疾患の処置、及び診断のための方法
US7329489B2 (en) 2000-04-14 2008-02-12 Matabolon, Inc. Methods for drug discovery, disease treatment, and diagnosis using metabolomics
US6500409B1 (en) 2000-05-10 2002-12-31 Colgate Palmolive Company Synergistic antiplaque/antigingivitis oral composition
DE10059584A1 (de) 2000-11-30 2002-06-06 Beiersdorf Ag Kosmetische oder dermatologische getränkte Tücher
US7005225B2 (en) 2002-11-12 2006-02-28 Samsung Electronics Company Organosol including amphipathic copolymeric binder having crystalline material, and use of the organosol to make dry tones for electrographic applications
WO2004073614A2 (en) 2003-02-14 2004-09-02 Combinatorx, Incorporated Combination therapy for the treatment of immunoinflammatory disorders
GB2401865A (en) 2003-05-22 2004-11-24 Givaudan Sa Antibacterial and antifungal glycerol monocarbonates
JP2007514648A (ja) 2003-10-24 2007-06-07 エーザイ株式会社 Toll−likereceptor2に関連する疾患及び状態を治療するための化合物及び方法
CA2546126A1 (en) 2003-12-03 2005-06-23 Christopher Hug Use of t-cadherin as a target
FI20040572A0 (fi) 2004-04-23 2004-04-23 Ctt Cancer Targeting Tech Oy Matriisi-metalloproteinaasin aktiviteetin inhibiittorit
US20050271601A1 (en) * 2004-06-02 2005-12-08 Nebojsa Milanovich Anti-staining antibacterial dentifrice
WO2006068133A1 (ja) * 2004-12-21 2006-06-29 National University Corporation NARA Institute of Science and Technology Nfat2発現抑制方法
US20060141421A1 (en) 2004-12-28 2006-06-29 Kimberly-Clark Worldwide, Inc. System and method for detecting substances related to oral health
WO2006074450A2 (en) 2005-01-07 2006-07-13 President And Fellows Of Harvard College Methods and compositions for detecting and modulating periodontal disorders and periodontal diseases
JP2009523029A (ja) 2006-01-10 2009-06-18 コルゲート・パーモリブ・カンパニー 炎症の予防または軽減のために、細胞表面受容体を調節する方法
US20080161394A1 (en) 2006-11-23 2008-07-03 Jean-Yves Fouron Cosmetic composition comprising at least one volatile carbonic acid ester
WO2008093072A2 (en) 2007-01-29 2008-08-07 Paul Webb Topical composition against contact dermatitis due to water
EP2207546A1 (en) 2007-10-09 2010-07-21 Humco Holding Group, Inc. Antifungal treatment of nails

Also Published As

Publication number Publication date
CN102549432B (zh) 2015-03-25
JP2012522994A (ja) 2012-09-27
WO2010115034A3 (en) 2010-12-29
EP2414837B1 (en) 2015-06-03
TW201102653A (en) 2011-01-16
MY179250A (en) 2020-11-02
RU2011144032A (ru) 2013-05-10
CA2753718A1 (en) 2010-10-07
CN102549432A (zh) 2012-07-04
US20120028261A1 (en) 2012-02-02
AR076041A1 (es) 2011-05-11
RU2523383C2 (ru) 2014-07-20
WO2010115034A2 (en) 2010-10-07
US8753820B2 (en) 2014-06-17
AU2010232593A1 (en) 2011-08-25
CO6430490A2 (es) 2012-04-30
TWI481870B (zh) 2015-04-21
CA2753718C (en) 2015-06-23
EP2414837A2 (en) 2012-02-08
BRPI1013184A2 (pt) 2016-04-12
JP5643288B2 (ja) 2014-12-17
SG173461A1 (en) 2011-09-29
MX2011008439A (es) 2011-09-06

Similar Documents

Publication Publication Date Title
IL217540A (en) Oral composition for use in oral disinfection or in treating an oral disease
PL2442814T3 (pl) Bifidobacteria do leczenia cukrzycy i pokrewnych chorób
EP2400916A4 (en) DENTAL AND MEDICAL TREATMENTS AND METHOD
BRPI1012116A2 (pt) composição farmacêutica para o tratamento de doenças cardíacas
PL2411504T3 (pl) Komórki ludzkiej tkanki pępowinowej jako terapia choroby Alzheimera
PT2510916T (pt) Composição farmacêutica antisséptica para a higiene oral e o tratamento de doenças bucais de origem microbiana
EP2182978A4 (en) TISSUE KALLIKREIN FOR THE TREATMENT OF DISEASES ASSOCIATED WITH AMYLOID PROTEIN
IL261742B (en) Human antibodies and their diagnostic and therapeutic uses for the treatment of neurological diseases
IL240560A0 (en) Compositions and methods for the diagnosis and treatment of tumor
WO2010115034A3 (en) Protein biomarkers for soft tissue disease diagnosis and as therapeutic targets for oral care intervention
EP2563395A4 (en) TREATMENT WITH ANTI-S1P ANTIBODY OF PATIENTS WITH OCULAR DISEASES
GB0815846D0 (en) diagnosis, prognosis and imaging of disease
EP2063902A4 (en) THERAPEUTIC CELL MEDICAMENT WITH STEM CELLS OF SKIN
GB0914423D0 (en) Treatment of protein aggregation diseases
EP2453837A4 (en) Implant for soft tissue reconstruction
EP2421554A4 (en) TISSUE KALLICREIN FOR THE TREATMENT OF HUNTINGTON'S DISEASE
PT2470066E (pt) Método não invasivo para avaliação da perfusão de tecidos num doente
IL219770A (en) Use of 5l and / or 3l to prepare a drug for use as a vaccine or diagnostic for parasitic disease
WO2011050096A9 (en) Methods and compositions for diagnosis and treatment of genetic and retinal disease
GB0709092D0 (en) Diagnosis and method of disease
EP2127681A4 (en) THERAPEUTIC AGENT AGAINST PARODONTAL DISEASES AND ALVEOLAR BONE LOSS THROUGH OPERATION
HK1167271A (en) Protein biomarkers for soft tissue disease diagnosis and as therapeutic targets for oral care intervention
HU0900195D0 (en) Diagnosis and treatment of gluten-induced autoimmune diseases
GB2447884B (en) Treatment for skin disease
GB0903858D0 (en) Diagnosis of disease